ArticleCureus2024
A Glimpse Into Rarity: A Phenomenal Case of Autoimmune Retinopathy in a Young Woman.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune retinopathy (AIR) is a rare retinal disorder that causes a gradual loss of vision due to autoantibodies targeting retinal antigens, leading to photoreceptor degeneration. Early diagnosis and timely intervention are critical for preserving visual function in affected patients. Over the course of a year, a 30-year-old woman had bilateral, abrupt, painless, progressive diminution of vision, nyctalopia, photopsia, and a restricted peripheral field of vision. No family history of night blindness was found. A diagnosis of AIR was suggested by the clinical examination, fundus fluorescein angiography (FFA), negative electroretinogram (ERG), and the short duration and quick progression of symptoms. A differential diagnosis of photoreceptor dystrophy was considered. Immunosuppressants and oral corticosteroids were started as treatment. Within a month of follow-up, the patient's vision had significantly improved. Despite the poor guarded prognosis of AIR, a favorable visual outcome was achieved through early detection and treatment with immunosuppressants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.